Riskpilot← Back to searchSign inGet full accessHINNAKLINIKKEN AS
ASActiveOrg 996401359Hinnasvingene 46, 4020 StavangerMedical specialists activities · NACE 8622Est. 20115 employees
Revenue 2024
NOK 7,2M
+5% vs 2023
EBITDA margin
31.3%
-8% vs 2023
Equity ratio
90.0%
Financial strength
Net profit 2024
NOK 1,7M
-2% vs 2023
| Revenue | NOK 7,2M | +5% |
| EBITDA | NOK 2,3M | -8% |
| Net profit | NOK 1,7M | -2% |
| Total assets | NOK 11,5M | +19% |
| Equity | NOK 10,3M | +19% |
| Employees | 5 | — |
Legal name
HINNAKLINIKKEN AS
Org number
996401359
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. januar 2011
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Omsetning av lege/helse tjenester med hovedområde innen gynekologi, samt omsetning av varer som står i forbindelse. Konsulent og investeringsvirksomhet. Med investeringsvirksomhet menes investering og lånefinansiert investering av enhver art, herunder investering i fast eiendom, løsøre og verdipapirer av enhver art. I tillegg skal selskapet drive med drift, utleie, framleie og salg av kapitalgjenstander, eiendom og løsøre.
Address
Hinnasvingene 46, 4020 Stavanger
Phone
+4751906868
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 194 | 6 650 | 6 841 | 6 891 | 7 235 |
| Staff expenses | −3 371 | −2 415 | −2 510 | −2 949 | −3 407 |
| EBITDA | 1 414 | 2 550 | 2 832 | 2 457 | 2 262 |
| Depreciation & amort. | −315 | −311 | −311 | −235 | −163 |
| EBIT | 1 099 | 2 239 | 2 521 | 2 222 | 2 099 |
| Net financials | −123 | −66 | −70 | −13 | 64 |
| Profit before tax | 977 | 2 173 | 2 451 | 2 209 | 2 163 |
| Tax | 215 | 478 | 539 | 486 | 476 |
| Net profit | 762 | 1 695 | 1 912 | 1 723 | 1 687 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 492 | 9 055 | 8 983 | 9 679 | 11 491 |
| Equity | 5 850 | 5 725 | 7 137 | 8 660 | 10 347 |
| Long-term debt | 3 792 | 2 182 | 568 | 14 | 20 |
| Short-term debt | 851 | 1 148 | 1 279 | 1 004 | 1 123 |
| Total debt | 4 642 | 3 330 | 1 846 | 1 019 | 1 144 |
EBITDA margin
31.3%
This company
15.8%
Market median
+98% vs market
20202024
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20202024
Return on equity
16.3%
This company
18.4%
Market median
+11% vs market
20202024
Net profit margin
23.3%
This company
8.1%
Market median
+188% vs market
20202024
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ØJ Deputy Member | Deputy Member | 2011 |
MV Chief Executive Officer | Chief Executive Officer | 2011 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HINNAKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Øyvind Jan Veholmen | Deputy Member | 0 companies |
| Marit Veholmen | Chief Executive Officer | 0 companies |